Cargando…
Topical Treatment of Recurrent Vulvovaginal Candidiasis: An Expert Consensus
Background: Recurrent vulvovaginal candidiasis (RVVC), defined as three or more confirmed infections over 1 year, occurs in up to 10% of women. In these women, the objective is often symptomatic control rather than mycologic cure. Current Centers for Disease Control and Prevention (CDC) guidelines r...
Autores principales: | Phillips, Nancy A., Bachmann, Gloria, Haefner, Hope, Martens, Mark, Stockdale, Colleen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812501/ https://www.ncbi.nlm.nih.gov/pubmed/35136875 http://dx.doi.org/10.1089/whr.2021.0065 |
Ejemplares similares
-
Clinical challenges in diagnosis and treatment of recurrent
vulvovaginal candidiasis
por: Neal, Chemen M, et al.
Publicado: (2022) -
Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022) -
Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
por: Grant, Leah M., et al.
Publicado: (2022) -
Systemic vs. Topical Therapy for the Treatment of Vulvovaginal Candidiasis
por: Faro, Sebastian
Publicado: (1994) -
Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
por: Rosati, Diletta, et al.
Publicado: (2020)